{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T05:40:06Z","timestamp":1756532406869,"version":"3.44.0"},"reference-count":29,"publisher":"Walter de Gruyter GmbH","issue":"10","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The sweat test is used as a biological marker of cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction, but there is growing recognition that sweat chloride concentrations of people with cystic fibrosis (CF) can overlap with those without CF. There are also people without CF whose symptoms are caused by abnormalities of CFTR. To support clinical decisions, the sweat chloride test conducted appropriately should provide consistent results between laboratories and common decision limits should be used. International consensus guidelines now recommend a standard set of clinical decision limits for sweat chloride, with values between 30 and 59\u202fmmol\/L, as the intermediate result for all ages. It is therefore timely to update the Australasian guideline decision limits to align with international consensus guidelines and peak body recommendations. At the same time, the technical aspects for performance of the sweat chloride test should be reviewed. This paper updates (and replaces) the guideline for the performance of the sweat chloride test that were last published by the AACB in 2017. This freely available guideline was developed to support Australasian laboratories, and laboratories from other regions, with the accurate performance of sweat chloride testing. The guideline provides 16 recommendations for the performance of the sweat chloride test encompassing the total testing process. Previous recommendations related to sweat conductivity testing have been removed from this guideline. The sweat chloride decision limits of\u00a0\u226530\u202fmmol\/L support a review by a CF physician for all age groups. Sweat chloride concentrations of\u00a0\u226560\u202fmmol\/L are supportive of a diagnosis of\u00a0CF.<\/jats:p>","DOI":"10.1515\/cclm-2025-0433","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T06:21:16Z","timestamp":1749190876000},"page":"1956-1964","source":"Crossref","is-referenced-by-count":0,"title":["Australasian guideline for the performance of sweat chloride testing 3rd edition: to support cystic fibrosis screening, diagnosis and monitoring"],"prefix":"10.1515","volume":"63","author":[{"given":"John","family":"Massie","sequence":"first","affiliation":[{"name":"Department of Respiratory and Sleep Medicine, The Royal Children\u2019s Hospital , Parkville , VIC , Australia"},{"name":"Department of Paediatrics , University of Melbourne , Parkville , VIC , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avis","family":"McWhinney","sequence":"additional","affiliation":[{"name":"Department of Mater Pathology, Mater Health Services , South Brisbane , QLD , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Greed","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry , PathWest Laboratory Medicine WA , Nedlands , WA , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Robbins","sequence":"additional","affiliation":[{"name":"Royal College of Pathologists Quality Assurance Programs , St Leonards , NSW , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Graham","sequence":"additional","affiliation":[{"name":"Royal College of Pathologists Quality Assurance Programs , St Leonards , NSW , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Heather","sequence":"additional","affiliation":[{"name":"LabPlus, Auckland City Hospital, Te Whatu Ora Health New\u00a0Zealand , Auckland , New\u00a0Zealand"},{"name":"Liggins Institute, University of Auckland , Auckland , New\u00a0Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5044-507X","authenticated-orcid":false,"given":"Carol Wai-Kwan","family":"Siu","sequence":"additional","affiliation":[{"name":"Department of Biochemical Genetics , Genetics & Molecular Pathology Directorate, SA Pathology, Women\u2019s & Children\u2019s Hospital , North Adelaide , Australia"},{"name":"School of Biomedicine, Faculty of Health and Medical Sciences , The University of Adelaide , Adelaide , SA , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Law","sequence":"additional","affiliation":[{"name":"New South Wales Newborn Screening Program, The Children\u2019s Hospital at Westmead, Sydney Children\u2019s Hospitals Network , Sydney , NSW , Australia"},{"name":"Faculty of Medicine and Health , University of Sydney , Sydney , NSW , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7823-8797","authenticated-orcid":false,"given":"Ronda F.","family":"Greaves","sequence":"additional","affiliation":[{"name":"Department of Paediatrics , University of Melbourne , Parkville , VIC , Australia"},{"name":"Victorian Clinical Genetics Services, Murdoch Children\u2019s Research Institute , Parkville , VIC , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"2025083005004171874_j_cclm-2025-0433_ref_001","doi-asserted-by":"crossref","unstructured":"Mishra, A, Greaves, R, Smith, K, Carlin, JB, Wootton, A, Stirling, R, et al.. Diagnosis of cystic fibrosis by sweat testing: age-specific reference intervals. J\u00a0Pediatr 2008;153:758\u201363. e1. https:\/\/doi.org\/10.1016\/j.jpeds.2008.04.067.","DOI":"10.1016\/j.jpeds.2008.04.067"},{"key":"2025083005004171874_j_cclm-2025-0433_ref_011","doi-asserted-by":"crossref","unstructured":"Farrell, PM, Rosenstein, BJ, White, TB, Accurso, FJ, Castellani, C, Cutting, GR, et al.. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: cystic Fibrosis Foundation consensus report. J\u00a0Pediatr 2008;153:S4\u2013s14. https:\/\/doi.org\/10.1016\/j.jpeds.2008.05.005.","DOI":"10.1016\/j.jpeds.2008.05.005"},{"key":"2025083005004171874_j_cclm-2025-0433_ref_015","unstructured":"Clinical and Laboratory Standards Institute. Sweat testing: specimen collection and quantitative chloride analysis, 5th ed. CLSI guideline C34. Wayne, PA, USA: CLSI; 2024:58 p."},{"key":"2025083005004171874_j_cclm-2025-0433_ref_002","doi-asserted-by":"crossref","unstructured":"Farrell, PM, White, TB, Ren, CL, Hempstead, SE, Accurso, F, Derichs, N, et al.. Diagnosis of cystic fibrosis: consensus guidelines from the cystic fibrosis foundation. J\u00a0Pediatr 2017;181:S4\u201315.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2016.09.064.","DOI":"10.1016\/j.jpeds.2016.09.064"},{"key":"2025083005004171874_j_cclm-2025-0433_ref_003","doi-asserted-by":"crossref","unstructured":"Castellani, C, Duff, AJA, Bell, SC, Heijerman, HGM, Munck, A, Ratjen, F, et al.. ECFS best practice guidelines: the 2018 revision. J\u00a0Cyst Fibros 2018;17:153\u201378. https:\/\/doi.org\/10.1016\/j.jcf.2018.02.006.","DOI":"10.1016\/j.jcf.2018.02.006"},{"key":"2025083005004171874_j_cclm-2025-0433_ref_004","unstructured":"Massie, J, Greaves, R, Metz, M, Wiley, V, Graham, P, Shepherd, S, et al.. Australasian guideline (2nd edition): an annex to the CLSI and UK guidelines for the performance of the sweat test for the diagnosis of cystic fibrosis. Clin Biochem Rev 2017;38:115\u201330."},{"key":"2025083005004171874_j_cclm-2025-0433_ref_005","doi-asserted-by":"crossref","unstructured":"Coakley, J, Scott, S, Mackay, R, Greaves, R, Jolly, L, Massie, J, et al.. Sweat testing for cystic fibrosis: standards of performance in Australasia. Ann Clin Biochem 2009;46:332\u20137. https:\/\/doi.org\/10.1258\/acb.2009.009023.","DOI":"10.1258\/acb.2009.009023"},{"key":"2025083005004171874_j_cclm-2025-0433_ref_006","unstructured":"Coakley, J, Scott, S, Doery, J, Greaves, R, Talsma, P, Whitham, E, et al.. Australian guidelines for the performance of the sweat test for the diagnosis of cystic fibrosis: report from the AACB Sweat Testing Working Party. Clin Biochem Rev 2006;27:S1\u20137."},{"key":"2025083005004171874_j_cclm-2025-0433_ref_013","unstructured":"Heap, S. Guidelines for the performance of the sweat test for the investigation of cystic fibrosis in the UK v.2. Assoc Lab Med 2014. https:\/\/www.exeterlaboratory.com\/images\/sweat-guideline-v2-1.pdf."},{"key":"2025083005004171874_j_cclm-2025-0433_ref_014","unstructured":"Clinical and Laboratory Standards Institute. Sweat testing: specimen collection and quantitative chloride analysis, 4th ed. CLSI guideline C34. Wayne, PA. USA: CLSI; 2019."},{"key":"2025083005004171874_j_cclm-2025-0433_ref_026","doi-asserted-by":"crossref","unstructured":"Collie, JT, Massie, RJ, Jones, OA, LeGrys, VA, Greaves, RF. Sixty\u2010five years since the New York heat wave: advances in sweat testing for cystic fibrosis. Pediatr Pulmonol 2014;49:106\u201317. https:\/\/doi.org\/10.1002\/ppul.22945.","DOI":"10.1002\/ppul.22945"},{"key":"2025083005004171874_j_cclm-2025-0433_ref_027","doi-asserted-by":"crossref","unstructured":"Legrys, VA, McColley, SA, Li, Z, Farrell, PM. The need for quality improvement in sweat testing infants after newborn screening for cystic fibrosis. J\u00a0Pediatr 2010;157:1035\u20137. https:\/\/doi.org\/10.1016\/j.jpeds.2010.07.053.","DOI":"10.1016\/j.jpeds.2010.07.053"},{"key":"2025083005004171874_j_cclm-2025-0433_ref_028","doi-asserted-by":"crossref","unstructured":"Accurso, FJ, Van Goor, F, Zha, J, Stone, AJ, Dong, Q, Ordonez, CL, et al.. Sweat chloride as a biomarker of CFTR activity: proof of concept and ivacaftor clinical trial data. J\u00a0Cyst Fibros 2014;13:139\u201347. https:\/\/doi.org\/10.1016\/j.jcf.2013.09.007.","DOI":"10.1016\/j.jcf.2013.09.007"},{"key":"2025083005004171874_j_cclm-2025-0433_ref_016","unstructured":"Sweat test procedure - guide for families; 2023. Available from: https:\/\/player.vimeo.com\/video\/837751686?h=4b12813bf2."},{"key":"2025083005004171874_j_cclm-2025-0433_ref_017","unstructured":"Sweat test procedure for health professionals; 2023. Avalilable from: https:\/\/player.vimeo.com\/video\/824919425?h=a9225797ab."},{"key":"2025083005004171874_j_cclm-2025-0433_ref_020","unstructured":"Mullen, K. Sweat sample stability test protocol and final report. South Logan, Utah, USA: Wescor Inc; 2008."},{"key":"2025083005004171874_j_cclm-2025-0433_ref_029","doi-asserted-by":"crossref","unstructured":"Collie, JT, Massie, J, Jones, OA, Morrison, PD, Greaves, RF. Sweat travels: the issue of sweat chloride transportation. Clin Chem Lab Med 2018;56:e36\u20138. https:\/\/doi.org\/10.1515\/cclm-2017-0506.","DOI":"10.1515\/cclm-2017-0506"},{"key":"2025083005004171874_j_cclm-2025-0433_ref_022","unstructured":"Joint Committee for Traceability in Laboratory Medicine (JCTLM). Database of higher-order reference materials, measurement methods\/procedures and services. Sevres Cedex France: International Bureau of Weights and Measures (BIPM)."},{"key":"2025083005004171874_j_cclm-2025-0433_ref_023","doi-asserted-by":"crossref","unstructured":"Collie, JT, Massie, RJ, Jones, OA, Morrison, PD, Greaves, RF. A candidate reference method using ICP-MS for sweat chloride quantification. Clin Chem Lab Med 2016;54:561\u20137. https:\/\/doi.org\/10.1515\/cclm-2015-0506.","DOI":"10.1515\/cclm-2015-0506"},{"key":"2025083005004171874_j_cclm-2025-0433_ref_007","unstructured":"Clinical and Laboratory Standards Institute. Sweat testing: sample collection and quantitative analysis: approved guideline. Wayne, Pennsylvania, USA: NCCLS; 1994."},{"key":"2025083005004171874_j_cclm-2025-0433_ref_008","unstructured":"Clinical and Laboratory Standards Institute. Sweat testing: sample collection and quantitative analysis: approved guideline. Wayne, Pennsylvania, USA: NCCLS; 2000."},{"key":"2025083005004171874_j_cclm-2025-0433_ref_009","doi-asserted-by":"crossref","unstructured":"Baumer, JH. Evidence based guidelines for the performance of the sweat test for the investigation of cystic fibrosis in the UK. Arch Dis Child 2003;88:1126\u20137. https:\/\/doi.org\/10.1136\/adc.88.12.1126.","DOI":"10.1136\/adc.88.12.1126"},{"key":"2025083005004171874_j_cclm-2025-0433_ref_010","doi-asserted-by":"crossref","unstructured":"Green, A, Kirk, J, Guidelines Development Group. Guidelines for the performance of the sweat test for the diagnosis of cystic fibrosis. Ann Clin Biochem 2007;44:25\u201334. https:\/\/doi.org\/10.1258\/000456307779596011.","DOI":"10.1258\/000456307779596011"},{"key":"2025083005004171874_j_cclm-2025-0433_ref_012","doi-asserted-by":"crossref","unstructured":"Castellani, C, Southern, KW, Brownlee, K, Dankert Roelse, J, Duff, A, Farrell, M, et al.. European best practice guidelines for cystic fibrosis neonatal screening. J\u00a0Cyst Fibros 2009;8:153\u201373. https:\/\/doi.org\/10.1016\/j.jcf.2009.01.004.","DOI":"10.1016\/j.jcf.2009.01.004"},{"key":"2025083005004171874_j_cclm-2025-0433_ref_018","doi-asserted-by":"crossref","unstructured":"Plebani, M. Exploring the iceberg of errors in laboratory medicine. Clin Chim Acta 2009;404:16\u201323. https:\/\/doi.org\/10.1016\/j.cca.2009.03.022.","DOI":"10.1016\/j.cca.2009.03.022"},{"key":"2025083005004171874_j_cclm-2025-0433_ref_019","doi-asserted-by":"crossref","unstructured":"Gibson, LE, Cooke, RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 1959;23:545\u20139. https:\/\/doi.org\/10.1542\/peds.23.3.545.","DOI":"10.1542\/peds.23.3.545"},{"key":"2025083005004171874_j_cclm-2025-0433_ref_021","doi-asserted-by":"crossref","unstructured":"Robbins, N, Massie, RJ, McWhinney, A, Heather, N, Greed, L, Graham, P, et al.. Is sweat conductivity still a relevant screening test for cystic fibrosis? Participation over 10 years. Clin Chem Lab Med 2025;63:e53\u20135. https:\/\/doi.org\/10.1515\/cclm-2024-0909.","DOI":"10.1515\/cclm-2024-0909"},{"key":"2025083005004171874_j_cclm-2025-0433_ref_025","unstructured":"Cystic Fibrosis Foundation Patient Registry. 2023 annual data report. Bethesda, Maryland: \u00a92024 Cystic Fibrosis Foundation; 2023."},{"key":"2025083005004171874_j_cclm-2025-0433_ref_024","doi-asserted-by":"crossref","unstructured":"Ozarda, Y, Sikaris, K, Streichert, T, Macri, J. Distinguishing reference intervals and clinical decision limits - a review by the IFCC Committee on Reference Intervals and Decision Limits. Crit Rev Clin Lab Sci 2018;55:420\u201331. https:\/\/doi.org\/10.1080\/10408363.2018.1482256.","DOI":"10.1080\/10408363.2018.1482256"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2025-0433\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2025-0433\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T05:02:34Z","timestamp":1756530154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2025-0433\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":29,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,5,22]]},"published-print":{"date-parts":[[2025,9,25]]}},"alternative-id":["10.1515\/cclm-2025-0433"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2025-0433","relation":{},"ISSN":["1434-6621","1437-4331"],"issn-type":[{"type":"print","value":"1434-6621"},{"type":"electronic","value":"1437-4331"}],"subject":[],"published":{"date-parts":[[2025,6,6]]}}}